The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,981.00
Bid: 1,985.00
Ask: 1,987.00
Change: 8.00 (0.41%)
Spread: 2.00 (0.101%)
Open: 1,967.00
High: 1,989.00
Low: 1,966.00
Prev. Close: 1,973.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: BAT Sees Strong 2019 Despite US Vape Slowdown

Wed, 27th Nov 2019 07:43

(Alliance News) - Stocks in London are set to open slightly higher on Wednesday amid US-China trade optimism, while the pound remained subdued ahead of a closely watched UK voting intention poll to be published later in the day.

In early UK company news, British American Tobacco said it expects a strong 2019 despite a challenging regulatory environment in the US for vaping products, while Marston's turned to an annual loss and Britvic reported a fall in full-year profit.

IG says futures indicate the FTSE 100 index of large-caps to open 23.76 points higher at 7,426.90 on Wednesday. The FTSE 100 index closed up 6.85 points, or 0.1%, at 7,403.14 on Tuesday.

"European markets finished a rather dull and uneventful session more or less unchanged yesterday, while US markets continued to make new record highs. Optimism around trade discussions has once again helped to underpin sentiment after reports that China's negotiator Liu He and US trade negotiator Robert Lighthizer had reached a consensus on how to resolve a number of core issues, while keeping lines of communication open with a view to resolving other remaining issues," commented Michael Hewson, chief market analyst at CMC Markets.

He continued: "It still remains unclear what the timing is likely to be on the agreement of a phase one deal, however with three weeks until December 15th, it's not hard to imagine that it is highly unlikely that we'll get anything tangible before that. This is the date when the next round of tariffs is scheduled to kick in and would suggest that President Trump will want to keep that option open until the very last moment."

In the US on Tuesday, Wall Street ended higher, with the Dow 30 up 0.2%, the S&P 500 also 0.2% higher and the Nasdaq Composite gaining 0.2%.

US President Donald Trump on Tuesday offered tepid support to Hong Kong pro-democracy protesters, saying he trusts President Xi Jinping to resolve the crisis, as US-Chinese trade talks enter their "final throes."

"We're with them," Trump said of the protesters who delivered a landslide victory for pro-democracy candidates in local elections and have battled police for weeks in street demonstrations.

But Trump immediately back-pedalled, emphasizing his close ties to Xi and efforts to secure a long-delayed resolution to the trade war between the world's two biggest economies. "We're in the final throes of a very important deal, I guess you could say one of the most important deals in trade ever," Trump said.

In Asia on Wednesday, the Japanese Nikkei 225 index closed up 0.3%. In China, the Shanghai Composite ended down 0.1%, while the Hang Seng index in Hong Kong is 0.1% higher in late trade.

In early UK company news, British American Tobacco said it expects revenue and profit growth towards the upper end of target despite a slowdown in the US vaping market.

The Lucky Strike cigarette maker said it expects full-year currency-adjusted revenue growth in the upper half of its 3% to 5% guidance range, with an adjusted operating margin improvement of 50 to 100 basis points. Constant-currency adjusted operating profit is expected in the upper half of its 5% to 7% guidance range.

In Combustibles, global industry volumes are expected to be down around 3.5% for the full-year, with BAT's volumes to be broadly in line with the wider market.

In New Categories, Vuse and Vype vapour products have grown market share, though full-year constant currency revenue growth for the division is expected at the lower end of its 30% to 50% range, BAT said, reflecting a slowdown in the US vapour market.

"We expect to deliver a strong performance in 2019, building on the good progress we made in the first half. Our focus on our global strategic brands is delivering share gains and strong price mix in combustibles, both globally and in the US," said Chief Executive Jack Bowles.

He added that legal issues around vaping in the US should "lead to a better and stronger regulatory environment", in which the company is "well placed to succeed".

Massachusetts became the first American state to issue an outright ban on all e-cigarette devices in September amid a spate of deaths and injuries linked to vaping across the country, with the prohibition to last for four months.

Hikma Pharmaceuticals said it has submitted its response to deficiencies in its abbreviated new drug application for a generic version of GlaxoSmithKline's Advair Diskus to the US Food & Drug Administration.

The submission addresses the outstanding questions raised by the FDA in its complete response letter.

"As we continue to develop our pipeline of complex generics, respiratory products are a key strategic focus for Hikma and our generic Advair submission is an important milestone. We are confident in our ability to bring a generic version of Advair to the US market," said Hikma Chief Executive Siggi Olafsson.

Pub operator Marston's swung to an annual loss though said it is making good progress on reducing debt.

Revenue for the year to September 28 edged up to GBP1.17 billion from GBP1.14 billion the year before, but the company swung to a loss of GBP20.0 million from a GBP54.3 million profit.

The firm's results were hit by a GBP43.4 million impairment of underperforming Destination and Premium properties, and GBP48.7 million loss reflecting interest rate swap valuation movements.

Pub like-for-like sales growth was 0.8%, while brewing volumes were 1% ahead of the prior year. Marston's said its trading performance in 2019 was strong in wet-led pubs and brewing, with more subdued sales in food-led outlets.

Net debt at the financial year end was GBP1.40 billion, up slightly from GBP1.39 billion a year ago, which the company said reflected investment in new sites.

However, Marston's said it is ahead of schedule in its aim to reduce net debt by GBP200 million by 2023, having reduced growth capital spend on new-build pubs and lodges in 2019. The firm has raised its pub disposal target for the 2020 financial year to GBP70 million from GBP40 million.

"As a result of this good progress we are aiming to achieve the debt reduction target in a shorter timeframe. When we achieve the target, our aim is to operate a high quality pub and beer business generating sustainable and consistent net cash flow after dividends of at least GBP50 million per annum," said Marston's, as it held its final dividend at 4.8p.

Soft drinks maker Britvic reported growth in annual revenue though profit took a hit from a write down of French assets.

Revenue increased 1.4% in the financial year to September 29 to GBP1.55 billion, though pretax profit slid 24% to GBP110.3 million from GBP145.8 million.

This fall in profit was due to adjusting items of GBP84.6 million, related to its business capability programme, past pension costs, and the closure of the Fruit Shoot multi-pack operation in the US, as well as additional adjusting items in relation to the proposed sale of the juice manufacturing sites in France.

The company said it expects to make further progress in 2020 despite the current macro-economic environment remaining uncertain.

IT infrastructure firm Softcat said it maintained strong trading momentum in its first quarter.

During the quarter to October 31, the FTSE 250 constituent said it once again delivered year-on-year growth in revenue, gross profit and operating profit.

"We've performed well during the first quarter of our new financial year. Customer numbers and gross profit per customer were both up on the prior period, and we again saw growth across all areas of technology and customer segments," said Chief Executive Graeme Watt.

In the economic calendar on Wednesday, US personal consumption expenditures, alongside an estimate of third-quarter gross domestic product, are at 1330 GMT.

Consensus, according to FXStreet, sees the latest estimate of third-quarter US GDP unchanged at 1.9% growth year-on-year.

In UK political news, opposition leader Jeremy Corbyn will try to steer his Labour party's campaign back towards the NHS today after a bruising day in which he was accused of not being fit to be prime minister by the UK's Chief Rabbi.

The Conservatives will also want to move the focus onto their agenda again after the party was accused by the Muslim Council of Britain of "denial, dismissal and deceit" with regards to Islamophobia within its ranks.

Corbyn is set to make "a major statement" on the NHS in Westminister on Wednesday morning and later he will address a climate change rally in Falmouth as he attempts to move the debate away from accusations of anti-Semitism in Labour.

Meanwhile, visiting the south west on Wednesday, UK Prime Minister Boris Johnson will set out plans for a "shared rural network" which would lead to new phone masts being built and existing infrastructure shared between the four mobile phone providers – O2, Three, Vodafone and EE – to strengthen signals in rural areas.

At 2200 GMT, market research firm YouGov is expected to release a closely-watched MRP - multiple-level regression and post-stratification - poll, which correctly forecast a hung parliament in 2017.

The pound was quoted at USD1.2838 early Wednesday, soft compared to USD1.2845 late Tuesday.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
22 Feb 2024 09:42

TOP NEWS: Hikma boosts dividend after year of "significant progress"

(Alliance News) - Shares in Hikma Pharmaceuticals PLC jumped on Thursday after it lifted the dividend by 29% amid better-than-expected annual profit.

Read more
22 Feb 2024 07:51

Hikma lifts dividend after double-digit growth in 2023

(Sharecast News) - Hikma Pharmaceuticals impressed the market with its annual results on Thursday as it bumped up its dividend by almost a third following double-digit growth in core revenues and profits in 2023.

Read more
15 Feb 2024 14:42

UK earnings, trading statements calendar - next 7 days

Friday 16 February 
NatWest Group PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 19 February 
Bank of Cyprus Holdings PLCFull Year Results
MoneySupermarket.com PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 20 February 
Antofagasta PLCFull Year Results
Barclays PLCFull Year Results
BHP Group LtdHalf Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Gran Tierra Energy IncFull Year Results
InterContinental Hotels Group PLCFull Year Results
Petra Diamonds LtdHalf Year Results
Springfield Properties PLCHalf Year Results
Wednesday 21 February 
BAE Systems PLCFull Year Results
Conduit Holdings LtdFull Year Results
Glencore PLCFull Year Results
HSBC Holdings PLCFull Year Results
Rio Tinto PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
Tate & Lyle PLCTrading Statement
Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
2 Feb 2024 07:23

Hikma agrees to settle US opioid claims

(Sharecast News) - Hikma Pharmaceuticals announced an agreement in principle to address the majority of opioid-related claims filed against it by various US states, local communities and tribal nations on Friday.

Read more
1 Feb 2024 20:00

EARNINGS AND TRADING: Tandem FY sales down 17%; Hikma's opioid deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
9 Jan 2024 09:29

LONDON BROKER RATINGS: Berenberg cuts target prices for miners

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Wednesday:

Read more
20 Dec 2023 09:25

LONDON BROKER RATINGS: UBS cuts DS Smith; Kepler likes Genus

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
19 Dec 2023 09:11

LONDON BROKER RATINGS: Peel Hunt raises Flutter to 'buy' from 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Nov 2023 13:08

Jefferies downgrades Hikma to 'hold'

(Sharecast News) - Jefferies downgraded Hikma Pharmaceuticals on Tuesday to 'hold' from 'buy' and cut the price target to 1,940p from 2,125p.

Read more
7 Nov 2023 09:28

LONDON BROKER RATINGS: Watches of Switzerland impresses HSBC; Asos cut

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Nov 2023 07:43

LONDON BRIEFING: AB Foods hails Primark; Beazley premiums rise

(Alliance News) - London's FTSE 100 is called to open in the red on Tuesday, following Asian equities lower, as the good feeling in equity markets after the softer US jobs data on Friday gives way to some caution.

Read more
6 Nov 2023 12:01

Berenberg stays at 'hold' on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg reiterated their 'hold' rating and 2,100.0p target price on Hikma Pharmaceuticals on Monday, saying a "lighter" second half was playing out in its injectables unit.

Read more
3 Nov 2023 09:31

LONDON BROKER RATINGS: JPMorgan lifts Smith & Nephew

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
2 Nov 2023 15:12

London close: Stocks rise as BoE keeps rates steady

(Sharecast News) - London's stock markets ended the day on a positive note on Thursday, following the Bank of England's decision to maintain interest rates as markets widely expected.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.